Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 10 studies | 34% ± 18% | |
kidney | 9 studies | 31% ± 15% | |
intestine | 9 studies | 28% ± 12% | |
peripheral blood | 7 studies | 24% ± 12% | |
liver | 6 studies | 31% ± 13% | |
uterus | 4 studies | 31% ± 20% | |
brain | 4 studies | 23% ± 5% | |
pancreas | 3 studies | 39% ± 3% | |
eye | 3 studies | 27% ± 6% | |
adrenal gland | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 36713.15 | 226 / 226 | 100% | 1020.30 | 406 / 406 |
ovary | 100% | 4285.07 | 180 / 180 | 100% | 342.41 | 430 / 430 |
kidney | 100% | 23731.03 | 89 / 89 | 100% | 409.22 | 900 / 901 |
brain | 100% | 5796.00 | 2637 / 2642 | 100% | 240.88 | 705 / 705 |
prostate | 100% | 5612.13 | 245 / 245 | 100% | 688.12 | 501 / 502 |
uterus | 100% | 3665.01 | 170 / 170 | 100% | 393.02 | 458 / 459 |
thymus | 100% | 5431.70 | 652 / 653 | 100% | 377.47 | 604 / 605 |
skin | 100% | 4928.81 | 1807 / 1809 | 100% | 274.65 | 471 / 472 |
adrenal gland | 100% | 8988.73 | 258 / 258 | 100% | 341.21 | 229 / 230 |
intestine | 100% | 6765.95 | 966 / 966 | 99% | 413.48 | 524 / 527 |
pancreas | 99% | 2903.84 | 326 / 328 | 100% | 296.42 | 178 / 178 |
stomach | 100% | 4829.52 | 359 / 359 | 99% | 334.91 | 284 / 286 |
bladder | 100% | 5207.38 | 21 / 21 | 99% | 460.63 | 499 / 504 |
esophagus | 100% | 5341.93 | 1444 / 1445 | 99% | 214.52 | 181 / 183 |
breast | 100% | 8622.36 | 459 / 459 | 99% | 372.45 | 1104 / 1118 |
lung | 98% | 3585.86 | 567 / 578 | 99% | 293.32 | 1145 / 1155 |
adipose | 100% | 10151.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 302.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 370.59 | 29 / 29 |
muscle | 100% | 8730.47 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3563.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 334.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 554.87 | 1 / 1 |
blood vessel | 100% | 4741.68 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 8210.26 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 2239.43 | 582 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0009083 | Biological process | branched-chain amino acid catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004300 | Molecular function | enoyl-CoA hydratase activity |
GO_0004165 | Molecular function | delta(3)-delta(2)-enoyl-CoA isomerase activity |
GO_0120092 | Molecular function | crotonyl-CoA hydratase activity |
GO_0005515 | Molecular function | protein binding |
GO_0043956 | Molecular function | 3-hydroxypropionyl-CoA dehydratase activity |
Gene name | ECHS1 |
Protein name | Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH) |
Synonyms | hCG_18928 |
Description | FUNCTION: Converts unsaturated trans-2-enoyl-CoA species ((2E)-enoyl-CoA) to the corresponding (3S)-3hydroxyacyl-CoA species through addition of a water molecule to the double bond . Catalyzes the hydration of medium- and short-chained fatty enoyl-CoA thioesters from 4 carbons long (C4) up to C16 . Has high substrate specificity for crotonyl-CoA ((2E)-butenoyl-CoA) and moderate specificity for acryloyl-CoA, 3-methylcrotonyl-CoA (3-methyl-(2E)-butenoyl-CoA) and methacrylyl-CoA ((2E)-2-methylpropenoyl-CoA) . Can bind tiglyl-CoA (2-methylcrotonoyl-CoA), but hydrates only a small amount of this substrate . Plays a key role in the beta-oxidation spiral of short- and medium-chain fatty acid oxidation . At a lower rate than the hydratase reaction, catalyzes the isomerase reaction of trans-3-enoyl-CoA species (such as (3E)-hexenoyl-CoA) to trans-2-enoyl-CoA species (such as (2E)-hexenoyl-CoA), which are subsequently hydrated to 3(S)-3-hydroxyacyl-CoA species (such as (3S)-hydroxyhexanoyl-CoA) (By similarity). . |
Accessions | A0A384MDW7 ENST00000368547.4 P30084 |